Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Mario, Turriziani"'
Autor:
Mario Turriziani, Valerio Izzi, Laura Masuelli, Monica Benvenuto, Massimo Fantini, Pamela Sacchetti, Roberto Bei, Andrea Modesti
Publikováno v:
ResearcherID
Carcinoembryonic antigen (CEA), a glycosylated protein of MW 180 kDa, is overexpressed in a wide range of human carcinomas, including colorectal, gastric, pancreatic, non-small cell lung and breast carcinomas. Accordingly, CEA is one of several oncof
Publikováno v:
Recent Patents on Anti-Cancer Drug Discovery. 5:172-187
Temozolomide (TMZ) is a monofunctional methylating agent which is spontaneously activated in aqueous solution into the dacarbazine metabolite 5-(3-methyl-1-triazeno)imidazole-4-carboxamide. This drug has been approved for the treatment of metastatic
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 4:25-36
Sucralfate is a basic aluminium salt of sucrose octasulphate which was orally employed for prevention and treatment of several gastrointestinal diseases including gastroesophageal reflux, gastric and duodenal ulcer. Recent studies have employed sucra
Autor:
Carmine Cardillo, Julio A. Panza, Davide Lauro, Angelo Scuteri, Roberto Leo, Micaela Iantorno, Massimo Federici, Michael J. Quon, Umberto Campia, Giulio Cesare Cocciolillo, Mario Turriziani, A. Fusco, Renato Lauro, Manfredi Tesauro, Stefano Rizza
Publikováno v:
Metabolism. 56:413-419
Endothelial dysfunction, insulin resistance, and elevated levels of circulating proinflammatory markers are among the earliest detectable abnormalities in people at risk for atherosclerosis. Accelerated atherosclerosis is a leading contributor to mor
Autor:
Mario Turriziani, L Levati, Lucio Tentori, Barry Gold, R. Madaio, Patrizia Vernole, Grazia Graziani, Dande P, P Lacal, Enzo Bonmassar, Ilaria Portarena, Alessandra Balduzzi
Publikováno v:
Scopus-Elsevier
Leukemia 14 (2000): 1451–1459.
info:cnr-pdr/source/autori:Tentori L., Vernole P., Lacal P.M., Madaio R., Portarena I., Levati L., Balduzzi A.,Turriziani M., Dande P., Gold B., Bonmassar E., Graziani G./titolo:Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemia cells./doi:/rivista:Leukemia/anno:2000/pagina_da:1451/pagina_a:1459/intervallo_pagine:1451–1459/volume:14
Leukemia 14 (2000): 1451–1459.
info:cnr-pdr/source/autori:Tentori L., Vernole P., Lacal P.M., Madaio R., Portarena I., Levati L., Balduzzi A.,Turriziani M., Dande P., Gold B., Bonmassar E., Graziani G./titolo:Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemia cells./doi:/rivista:Leukemia/anno:2000/pagina_da:1451/pagina_a:1459/intervallo_pagine:1451–1459/volume:14
Mismatch repair deficiency contributes to tumor cell resistance to O6-guanine methylating compounds and to other antineoplastic agents. Here we demonstrate that MeOSO2(CH2)2- lexitropsin (Me-Lex), a DNA minor groove alkylating compound which generate
Publikováno v:
Journal of Chemotherapy. 8:394-398
Telomerase is a ribonucleoprotein enzyme which is involved in the maintenance of chromosome ends. Telomerase activity (TLMA) is required for cell immortality and can be considered a ubiquitous tumor marker. In this study we describe a new approach fo
Autor:
Ivan Monteleone, Giovanni Monteleone, Roberta Caruso, Flavio Caprioli, Francesco Pallone, Omero Alessandro Paoluzi, Manfredi Tesauro, Mario Turriziani, Giovanna Del Vecchio Blanco
Background Helicobacter pylori (Hp)-related gastritis is characterized by a predominant T helper (Th)1/Th17 cell immunity. Ghrelin (GR) has immunoregulatory properties and inhibits experimental Th cell-dependent pathology. Aims To evaluate whether Hp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234e69450bea9981f53c2505896d825c
http://hdl.handle.net/2108/121240
http://hdl.handle.net/2108/121240
Autor:
M. M. De Santi, Elena Bestoso, Mario Turriziani, Susanna Mannucci, Alberto Abbruzzese, M. Marra, Serena Apollinari, M. Del Vecchio, Pierosandro Tagliaferri, Angelo Aquino, C. Botta, Michele Caraglia, G. Gori Savellini, Pierpaolo Correale, Laura Bonmassar, Maria Grazia Cusi
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor receptor, approved for colorectal carcinoma treatment in combination with chemotherapy. The immune-mediated effects elicited by its human fraction of crysta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af169797f3d20eeb7b02256649ee9761
http://hdl.handle.net/11365/23653
http://hdl.handle.net/11365/23653
Autor:
Laura Masuelli, Roberto Bei, Camilla Palumbo, Michele Malaguarnera, Mario Turriziani, Fabio Galvano, Giovanni Vanni Frajese, Giovanni Li Volti
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1439e3b3bca37e2306786474e3f91140
http://hdl.handle.net/11580/24865
http://hdl.handle.net/11580/24865
Autor:
Florigio Lista, Roberto Bei, Elena Bonanno, Laura Masuelli, Mario Roselli, V. Sini, Laura Marzocchella, Oreste Claudio Buonomo, Andrea Modesti, Mario Turriziani, Augusto Orlandi, Vittorio Manzari
A common carboxyl-terminal epitope (C-22 P0) of the ribosomal P proteins (P0, P1 and P2) was shown to elicit autoantibodies in systemic lupus erythematosus (SLE) and in head and neck cancer patients. In this report we provide evidence for the in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67bc3065731b44bd28cf04bfec2468b2
http://hdl.handle.net/2108/53013
http://hdl.handle.net/2108/53013